An Act relative to APOL1 mediated kidney disease
Generates a plain-language summary of the bill text and history.
| Committee | Recommendation | Vote |
|---|---|---|
| J16 | Accompanied | 1 entries |
| Bill | Title | Status |
|---|---|---|
| S1545 | An Act relative to APOL1 mediated kidney disease | Active |
Chapter 111 of the General Laws is hereby amended by inserting after section 244, the following section:-
The department of public health shall conduct a review and issue a report on variants of the apolipoprotein L 1 (APOL 1) gene associated with increased risk of end-stage renal disease. The report must include: (1) Recommendations on how to increase awareness for APOL 1, including screening and genetic testing; (2) An analysis of strategies and funding to increase screening and genetic testing for APOL 1 in the commonwealth; and (3) Other relevant information or issues identified by the department. The department of public health shall file the report with the clerks of the house of representatives and the senate and the joint committee on public health no later than December 31, 2026.
Chapter 111 of the General Laws is hereby amended by inserting after section 244, the following section:- Section 245. The department of public health shall conduct a review and issue a report on variants of the apolipoprotein L 1 (APOL 1) gene associated with increased risk of end-stage renal disease. The report must include: (1) Recommendations on how to increase awareness for APOL 1, including screening and genetic testing; (2) An analysis of strategies and funding to increase screening and genetic testing for APOL 1 in the commonwealth; and (3) Other relevant information or issues identified by the department. The department of public health shall file the report with the clerks of the house of representatives and the senate and the joint committee on public health no later than December 31, 2026.